🟢 TEM surges 4.1% after announcing dozens of studies to be presented at major oncology conference

TEM is trading at $48.07 (+4.1%) after the company announced significant upcoming data presentations.

• Tempus announced that 37 abstracts have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
• The presentations will feature the company's AI-driven tools and highlight its work in precision medicine across various cancers.
• The positive company-specific news is a likely driver for the stock's gains, which are also supported by a broader market rally today.